Moderate riskFDA DrugClass II

Accord Healthcare levothyroxine sodium tablets recalled for subpotent drug

Accord Healthcare is recalling specific lots of levothyroxine sodium 112 mcg tablets because they contain less active ingredient than labeled. This means patients taking these tablets may not receive the full thyroid hormone dose they need. The recall affects 1000-count bottles distributed nationwide.

From the FDA notice · Read the official notice ↗

What to do

  1. Check your levothyroxine bottle for lot number D2402443, D2402444, or D2402445 with expiration date 10/31/2026.
  2. If you have an affected lot, contact your pharmacy or doctor before stopping or replacing your medication.
  3. Do not stop taking levothyroxine without medical guidance, as thyroid hormone replacement is essential.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-452-17.
Sold in
Nationwide
Made for
Adults (0 months and older)

This recall covers 12 products — see all of them.

Details

Units affected
N/A
Illnesses reported
None reported
Manufactured in
8041 Arco Corporate Dr Ste 200, N/A, Raleigh, NC, United States
Classification
Class II
Recall number
D-0780-2026

In the FDA's words

Description
Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 1000-count bottles, Rx Only, Manufactured for: Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-452-17. Subpotent Drug Lot #: D2402443, D2402444, D2402445, Exp. Date 10/31/2026. Distribution: Nationwide within the United States Affected quantity: N/A
Hazard
Subpotent Drug

12 products in this recall

The agency lists each product separately. Check every one you might have.

Related topics

PotencyDrugsSold nationwideMore from FDA Drug